What it's used for
Carbidopa and levodopa extended-release tablets are used to treat Parkinson's disease. They are also prescribed for post-encephalitic parkinsonism and symptomatic parkinsonism following carbon monoxide or manganese intoxication.
Source: U.S. FDA-approved prescribing information (openFDA).
Typical dosing
The daily dosage must be determined by careful titration, utilizing tablets containing carbidopa and levodopa in a 1:4 ratio.
Dosing shown here is the general FDA-labeled range. Your prescribing clinician determines the exact dose, form, and schedule for you — this is not a substitute for medical advice.
Boxed warning / key safety info
When switching from levodopa without a decarboxylase inhibitor, levodopa must be discontinued at least twelve hours before starting this medication.
Common side effects
The adverse experience profile of the extended-release formulation is similar to that of immediate-release formulations, involving motor fluctuations and related symptoms.
Covered strengths on the Tab $0 list
Covered at $0 with an active Tab membership when filled at a participating pharmacy nationwide or through mail order. A licensed clinician must prescribe the medication.
Related medications
Other everything else medications covered at $0 with an active Tab membership.